2023 Duke-International Society for Cardiovascular Infectious Diseases (ISCVID) Criteria

2023 Duke-ISCVID Update

This tool is based on the 2023 International Society for Cardiovascular Infectious Diseases criteria.

View Classic Duke Criteria

ورودی‌های بالینی بیمار

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
diagnosis
—diagnosis
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Definite IE2–99
  • Possible IE1–1
  • Rejected0–0
Direct Clinical Answer

The 2023 Duke-International Society for Cardiovascular Infectious Diseases (ISCVID) Criteria calculates predicting invasive bacterial infection probability and quantifying systemic host response to sepsis. Key inputs include microbiologic major typical. Scores guide administering empiric broad-spectrum antimicrobial regimens, infectious source control, and isolation protocols. Routine clinical application promotes standardized evidence-based patient management.

Clinical Guidelines & Evidence

Diagnostic criteria for infective endocarditis, updated from the original Duke criteria with improved sensitivity and specificity.

Clinical Indication

The 2023 Duke-International Society for Cardiovascular Infectious Diseases (ISCVID) Criteria is indicated for bedside clinical practice to support Diagnostic criteria for infective endocarditis, updated from the original Duke criteria with improved sensitivity and specificity.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients presenting with suspected sepsis, meningitis, pneumonia, COVID-19, opportunistic infections, or fever of unknown origin. Clinical application is indicated across Infectious disease services, septic shock bays, febrile illness clinics, and isolation units.

Limitations & Contraindications

Timely administration of empiric antibiotic therapy in suspected septic shock must never be delayed for score tabulation.

Clinical Pearls & Action Plan

Blood and site-specific microbiological cultures should be secured prior to administering broad-spectrum antimicrobials.

Formula & Variables:

Diagnostic algorithm based on pathologic criteria (definite if present), major criteria (microbiologic, imaging, surgical), and minor criteria (predisposing conditions, clinical manifestations). Definite IE: 2 major criteria OR 1 major + 3 minor criteria OR 5 minor criteria. Possible IE: 1 major + 1 minor criteria OR 3 minor criteria.

Input Parameters

NameTypeRequiredDescription
microbiologic_major_typicalstringNoMicroorganisms that commonly cause IE isolated from 2 or more separate blood culture sets
microbiologic_major_nontypicalstringNoMicroorganisms that occasionally or rarely cause IE isolated from 3 or more separate blood culture sets
pcr_positive_coxiella_bartonella_tropherymastringNoPositive PCR or nucleic acid-based technique for Coxiella burnetii, Bartonella species, or Tropheryma whipplei from blood
coxiella_antibody_titerstringNoCoxiella burnetii antiphase I IgG antibody titer >1:800, or isolated from single blood culture
bartonella_antibody_titerstringNoIndirect IFA for Bartonella henselae or quintana with IgG titer ≥1:800
imaging_major_echo_ctstringNoEchocardiography/cardiac CT showing vegetation, perforation, aneurysm, abscess, pseudoaneurysm, or fistula
new_valvular_regurgitationstringNoSignificant new valvular regurgitation on echocardiography compared with previous imaging
prosthetic_valve_dehiscencestringNoNew partial dehiscence of prosthetic valve compared with previous imaging
pet_ct_abnormal_activitystringNo[18F]FDG PET/CT abnormal metabolic activity involving valve, graft, device leads, or prosthetic material
surgical_evidencestringNoEvidence of IE documented by direct inspection during heart surgery
previous_iestringNoPrevious history of infective endocarditis
prosthetic_valvestringNoProsthetic valve present
previous_valve_repairstringNoPrevious valve repair
congenital_heart_diseasestringNoCongenital heart disease
significant_regurgitation_stenosisstringNoMore than mild regurgitation or stenosis of any etiology
endovascular_ciedstringNoEndovascular cardiac implantable electronic device (CIED)
hypertrophic_cardiomyopathystringNoHypertrophic obstructive cardiomyopathy
injection_drug_usestringNoInjection drug use
feverstringNoFever with documented temperature >38.0°C (100.4°F)
vascular_phenomenastringNoVascular phenomena (emboli, septic infarcts, mycotic aneurysm, hemorrhage, Janeway lesions)
immunologic_phenomenastringNoImmunologic phenomena (RF+, Osler nodes, Roth spots, glomerulonephritis)
positive_blood_cultures_minorstringNoPositive blood cultures for microorganism consistent with IE but not meeting major criterion
positive_sterile_site_culturestringNoPositive culture/PCR from sterile body site other than cardiac tissue or arterial embolus
pet_ct_within_3_monthsstringNoAbnormal [18F]FDG PET/CT activity within 3 months of prosthetic material implantation
new_regurgitation_auscultationstringNoNew valvular regurgitation on auscultation (if echo not available)
pathologic_microorganismsstringNoMicroorganisms identified in vegetation with clinical signs of active endocarditis
pathologic_active_endocarditisstringNoActive endocarditis identified in or on vegetation histologically

Score Interpretation & Guidance

RangeStageDescription
2–99Definite IEMeets criteria for definite infective endocarditis
1–1Possible IEMeets criteria for possible infective endocarditis
0–0RejectedDoes not meet criteria for infective endocarditis

Evidence-Based References (EBM)

  • Fowler VG Jr, Durack DT, Selton-Suty C, et al. The 2023 Duke-International Society for Cardiovascular Infectious Diseases Criteria for Infective Endocarditis: Updating the Modified Duke Criteria. Clin Infect Dis. 2023;77(4):518-526.
  • Cahill TJ, Baddour LM, Habib G, et al. Challenges in Infective Endocarditis. J Am Coll Cardiol. 2017;69(3):325-344.
  • Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESC Guidelines for the management of infective endocarditis. Eur Heart J. 2015;36(44):3075-3128.

Related calculators